In the midst of everything that is going on with COVID-19 it is easy to see how important non coronavirus stuff can get overlooked. But we still need to keep our eyes open. After a 3 year process involving many meetings, stakeholder comments, high levels of oversight and fantastic technical support, the National Institute of Health and Care Excellence in the UK (NICE) released their updated guidelines on the diagnosis and management of venous thromboembolic (VTE) disease.Continue Reading
Acute DVT, symptomatic chronic DVTs and Post Thrombotic Syndrome… it’s time to find out more.
Post thrombotic syndrome (PTS) is a common, but often underappreciated complication of deep vein thrombosis (DVT).
Venous thromboembolism (VTE) is the term used to describe a blood clot in the venous system of the body. Veins carry blood back toward the heart after the blood has been pumped to different parts of the body and the oxygen used. When a blood clot obstructs a vein, the blockage slows or can even stop blood flow. Whilst not the case for everyone, when veins become blocked, they can cause painful and difficult to manage symptoms. In particular the larger veins in the pelvis, the iliac veins, are prone to this problem.Continue Reading
Updated 2019 ESC Guidelines for the diagnosis of acute pulmonary embolism in collaboration with ERS - Has learning from DiPEP been overlooked?
Thrombosis UK’s concern following the publication of the 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)Continue Reading
Updated 2018 NICE guidance on venous thromboembolism – does evidence from root cause analysis of hospital‐associated thrombosis support the additional investment required?
The 2018 updated National Institute for Health and Care Excellence (NICE) guidance on venous thromboembolism (VTE) (NICE 2018)includes significant changes and extensions to the 2010 guidance on VTE risk assessment and thromboprophylaxis for hospital patients (NICE 2010).Continue Reading
NICE NG89 recommendations for extended pharmacological thromboprophylaxis – is it justified and is it cost effective: a rebuttal from the British Society for Haematology
We are writing to express our collective concern about the recommendation in the National Institute for Health and Care Excellence (NICE) guideline [NG89].Continue Reading
Response: NICE NG89 recommendations for extended pharmacological thromboprophylaxis – is it justified and is it cost effective: a rebuttal from the British Society for Haematology – response to Lester et alContinue Reading
Could a simple blood test catch cancer before symptoms appear? Nicola Davis goes beyond the hype and investigates the future of blood diagnostics and cancer.Continue Reading
While there are already some NICE guidelines for psychiatry, which point at the NICE VTE prophylaxis tool, the tool itself is often irrelevant to psychiatry. Patients often have no co-morbid medical illness, and the majority of them are walking around the ward, and off the ward, just like they would at home. Most of my patients do not need VTE prophylaxis.Continue Reading